Insurance M&A activity declines to 16-quarter low, but is higher than a decade ago and private equity interest remains strong, according to OPTIS Partners analysis.
This year, 6 brokers from across the brokerage field were named as the 2023 M&A Power Broker winners. An additional five brokers were named as finalists.
Digital transformation, clinical trials, climate change and product recalls are among the top risks and opportunities facing the life sciences sector over the next several years.
This year, six brokers from across the brokerage field were named as the 2022 M&A Power Broker winners. An additional four brokers were named as finalists.